ArticleTherapeutic advances in gastroenterology2026
Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023.
Keitaro Shimozaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.